GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: non-peptide stopped being a problem at week 16 — 11 comments in the full submission. View in context.
120
c/orforglipron·submitted 18 days ago by u/dilara_weiss

small win: non-peptide stopped being a problem at week 16

Paperbranch of 4 comments

Been lurking in c/t2dglp1 for about 20 months and finally have something worth posting. Short version: week 39, 2.5mg, and ATTAIN is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 23 threads, and the answers split roughly down the middle. What I actually want to know is…

Read the full submission and all 11 comments →

This branch

4 comments, started 16 days ago
u/enzo_ferrari0 points·16 days ago

Poland here. Waited 15 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink
u/dilara_weissOP1 point·16 days ago

Came off after 60 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.

replysharereportpermalink
u/lina_novak1 point·16 days ago

This is correct. ATTAIN data is phase 21.

replysharereportpermalink
u/dilara_weissOP1 point·16 days ago

Slight fix: the number was 97.6, not 98.3. Decimal point, but a fairly consequential one.

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/orforglipron
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/phase_two_peteu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →